Geode Capital Management
IRD

Geode Capital Management’s Opus Genetics IRD Stock Holding History

Geode Capital Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.45M Buy
538,347
+33,364
+7% +$115K ﹤0.01% 3047
2025
Q4 		$1.02M Buy
504,983
+36,046
+8% +$73.2K ﹤0.01% 3372
2025
Q3 		$774K Buy
468,937
+113,260
+32% +$141K ﹤0.01% 3477
2025
Q2 		$335K Buy
355,677
+2,268
+0.6% +$2.1K ﹤0.01% 3687
2025
Q1 		$347K Buy
353,409
+39,425
+13% +$44K ﹤0.01% 3672
2024
Q4 		$374K Buy
313,984
+41,703
+15% +$47.9K ﹤0.01% 3697
2024
Q3 		$357K Buy
272,281
+6,427
+2% +$9.9K ﹤0.01% 3708
2024
Q2 		$407K Buy
265,854
+31,456
+13% +$54.4K ﹤0.01% 3644
2024
Q1 		$471K Buy
234,398
+15,285
+7% +$38.8K ﹤0.01% 3641
2023
Q4 		$660K Hold
219,113
– – ﹤0.01% 3509
2023
Q3 		$734K Buy
219,113
+25,064
+13% +$101K ﹤0.01% 3451
2023
Q2 		$842K Buy
194,049
+12,679
+7% +$60.2K ﹤0.01% 3419
2023
Q1 		$680K Buy
181,370
+8,303
+5% +$29.8K ﹤0.01% 3528
2022
Q4 		$610K Buy
173,067
+21,498
+14% +$56.6K ﹤0.01% 3575
2022
Q3 		$304K Buy
151,569
+4,110
+3% +$8.87K ﹤0.01% 3981
2022
Q2 		$283K Buy
147,459
+17,535
+13% +$39.9K ﹤0.01% 4059
2022
Q1 		$420K Buy
129,924
+38,856
+43% +$133K ﹤0.01% 4028
2021
Q4 		$339K Buy
91,068
+12,145
+15% +$48.7K ﹤0.01% 4236
2021
Q3 		$406K Buy
78,923
+53,329
+208% +$246K ﹤0.01% 4132
2021
Q2 		$135K Buy
25,594
+14,294
+126% +$71K ﹤0.01% 4477
2021
Q1 		$65K Buy
+11,300
New +$105K ﹤0.01% 4373
2020
Q4 		– Sell
-6,645
Closed -$55K – 4290
2020
Q3 		$55K Hold
6,645
– – ﹤0.01% 4000
2020
Q2 		$75K Hold
6,645
– – ﹤0.01% 3921
2020
Q1 		$47K Hold
6,645
– – ﹤0.01% 3934
2019
Q4 		$50K Hold
6,645
– – ﹤0.01% 4089
2019
Q3 		$54K Hold
6,645
– – ﹤0.01% 4056
2019
Q2 		$137K Hold
6,645
– – ﹤0.01% 3880
2019
Q1 		$162K Buy
6,645
+3,602
+118% +$119K ﹤0.01% 3788
2018
Q4 		$135K Hold
3,043
– – ﹤0.01% 3793
2018
Q3 		$260K Hold
3,043
– – ﹤0.01% 3686
2018
Q2 		$205K Hold
3,043
– – ﹤0.01% 3710
2018
Q1 		$220K Hold
3,043
– – ﹤0.01% 3662
2017
Q4 		$295K Hold
3,043
– – ﹤0.01% 3544
2017
Q3 		$353K Hold
3,043
– – ﹤0.01% 3475
2017
Q2 		$417K Buy
3,043
+355
+13% +$69K ﹤0.01% 3422
2017
Q1 		$658K Buy
2,688
+779
+41% +$101K ﹤0.01% 3204
2016
Q4 		$130K Hold
1,909
– – ﹤0.01% 3734
2016
Q3 		$192K Hold
1,909
– – ﹤0.01% 3622
2016
Q2 		$230K Hold
1,909
– – ﹤0.01% 3538
2016
Q1 		$302 Hold
1,909
– – ﹤0.01% 3475
2015
Q4 		$332K Hold
1,909
– – ﹤0.01% 3463
2015
Q3 		$476K Hold
1,909
– – ﹤0.01% 3242
2015
Q2 		$556K Hold
1,909
– – ﹤0.01% 3149
2015
Q1 		$668K Hold
1,909
– – ﹤0.01% 3063
2014
Q4 		$641K Hold
1,909
– – ﹤0.01% 3065
2014
Q3 		$742K Buy
1,909
+420
+28% +$151K ﹤0.01% 2965
2014
Q2 		$621K Buy
1,489
+432
+41% +$196K ﹤0.01% 3054
2014
Q1 		$548K Buy
1,057
+480
+83% +$260K ﹤0.01% 3108
2013
Q4 		$141K Hold
577
– – ﹤0.01% 3518
2013
Q3 		$125K Buy
577
+71
+14% +$16.6K ﹤0.01% 3451
2013
Q2 		$108K Buy
+506
New +$86.8K ﹤0.01% 3414

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Geode Capital Management's IRD Position: Q1 2026 in Review

Geode Capital Management increased its Opus Genetics (IRD) stake by 6.6% in Q1 2026, buying an estimated $115K and bringing the position to 538,347 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3047.

Geode Capital Management first reported a position in IRD in Q2 2013 and has held it in 51 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Geode Capital Management held 538,347 shares of Opus Genetics worth $2.45M as of Q1 2026.
  • Geode Capital Management bought 33,364 Opus Genetics shares in Q1 2026, an estimated $115K.
  • Opus Genetics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3047 holding.
  • Geode Capital Management first reported a position in Opus Genetics in Q2 2013 and has held it in 51 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.